421 related articles for article (PubMed ID: 21825071)
1. The cell biology of disease: cellular mechanisms of cardiomyopathy.
Harvey PA; Leinwand LA
J Cell Biol; 2011 Aug; 194(3):355-65. PubMed ID: 21825071
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster.
Matsuhisa S; Otani H; Okazaki T; Yamashita K; Akita Y; Sato D; Moriguchi A; Iwasaka T
Antioxid Redox Signal; 2008 Dec; 10(12):1999-2008. PubMed ID: 18665799
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death.
Princen F; Bard E; Sheikh F; Zhang SS; Wang J; Zago WM; Wu D; Trelles RD; Bailly-Maitre B; Kahn CR; Chen Y; Reed JC; Tong GG; Mercola M; Chen J; Feng GS
Mol Cell Biol; 2009 Jan; 29(2):378-88. PubMed ID: 19001090
[TBL] [Abstract][Full Text] [Related]
5. Low-dose radiation prevents type 1 diabetes-induced cardiomyopathy via activation of AKT mediated anti-apoptotic and anti-oxidant effects.
Zhang F; Lin X; Yu L; Li W; Qian D; Cheng P; He L; Yang H; Zhang C
J Cell Mol Med; 2016 Jul; 20(7):1352-66. PubMed ID: 26991817
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
Kim KH; Oudit GY; Backx PH
J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol Protects the Myocardium in Sepsis by Activating the Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway and Inhibiting the Nuclear Factor-κB (NF-κB) Signaling Pathway.
Shang X; Lin K; Yu R; Zhu P; Zhang Y; Wang L; Xu J; Chen K
Med Sci Monit; 2019 Dec; 25():9290-9298. PubMed ID: 31806860
[TBL] [Abstract][Full Text] [Related]
8. Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling.
Worou ME; Belmokhtar K; Bonnet P; Vourc'h P; Machet MC; Khamis G; Eder V
Cardiovasc Res; 2011 Jul; 91(2):320-9. PubMed ID: 21406596
[TBL] [Abstract][Full Text] [Related]
9. Connexin43 and zonula occludens-1 are targets of Akt in cardiomyocytes that correlate with cardiac contractile dysfunction in Akt deficient hearts.
Ock S; Lee WS; Kim HM; Park KS; Kim YK; Kook H; Park WJ; Lee TJ; Abel ED; Kim J
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1183-1191. PubMed ID: 29378301
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PHLPP1 ameliorates cardiac dysfunction via activation of the PI3K/Akt/mTOR signalling pathway in diabetic cardiomyopathy.
Zhang M; Wang X; Liu M; Liu D; Pan J; Tian J; Jin T; Xu Y; An F
J Cell Mol Med; 2020 Apr; 24(8):4612-4623. PubMed ID: 32150791
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle.
Vikhorev PG; Vikhoreva NN
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065175
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K/Akt signaling pathway via PIK3CA.
Yang X; Li X; Lin Q; Xu Q
Gene; 2019 Oct; 715():143995. PubMed ID: 31336140
[TBL] [Abstract][Full Text] [Related]
13. Metabolism in cardiomyopathy: every substrate matters.
Ritterhoff J; Tian R
Cardiovasc Res; 2017 Mar; 113(4):411-421. PubMed ID: 28395011
[TBL] [Abstract][Full Text] [Related]
14. Mice with cardiac-restricted overexpression of Myozap are sensitized to biomechanical stress and develop a protein-aggregate-associated cardiomyopathy.
Frank D; Rangrez AY; Poyanmehr R; Seeger TS; Kuhn C; Eden M; Stiebeling K; Bernt A; Grund C; Franke WW; Frey N
J Mol Cell Cardiol; 2014 Jul; 72():196-207. PubMed ID: 24698889
[TBL] [Abstract][Full Text] [Related]
15. Intermittent hypoxia-induced cardiomyopathy and its prevention by Nrf2 and metallothionein.
Zhou S; Yin X; Jin J; Tan Y; Conklin DJ; Xin Y; Zhang Z; Sun W; Cui T; Cai J; Zheng Y; Cai L
Free Radic Biol Med; 2017 Nov; 112():224-239. PubMed ID: 28778483
[TBL] [Abstract][Full Text] [Related]
16. Female ClockΔ19/Δ19 mice are protected from the development of age-dependent cardiomyopathy.
Alibhai FJ; Reitz CJ; Peppler WT; Basu P; Sheppard P; Choleris E; Bakovic M; Martino TA
Cardiovasc Res; 2018 Feb; 114(2):259-271. PubMed ID: 28927226
[TBL] [Abstract][Full Text] [Related]
17. Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway.
Wang X; Pan J; Liu D; Zhang M; Li X; Tian J; Liu M; Jin T; An F
J Cell Mol Med; 2019 Aug; 23(8):5349-5359. PubMed ID: 31131539
[TBL] [Abstract][Full Text] [Related]
18. Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival.
Matsui T; Nagoshi T; Rosenzweig A
Cell Cycle; 2003; 2(3):220-3. PubMed ID: 12734428
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
Wu W; Liu X; Han L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
[TBL] [Abstract][Full Text] [Related]
20. Physiologic growth and pathologic genes in cardiac development and cardiomyopathy.
Dorn GW
Trends Cardiovasc Med; 2005 Jul; 15(5):185-9. PubMed ID: 16165015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
